Clinical Report: Dual Light Therapy Device for Dry Eye and OSD Management

Overview

Essilor Instruments has introduced the eye-light® device, which combines Optimal Power Energy™ Intense Pulsed Light (OPE™ IPL) and Light Modulation™ Low-level Light Therapy (LM™ LLLT) for managing ocular surface diseases (OSD) and dry eye. Clinical studies indicate that this dual therapy approach offers superior improvements in tear film quality and patient symptoms compared to IPL-only solutions.

Background

Dry eye disease (DED) affects a significant portion of the global population, leading to decreased quality of life and functional impairments. Traditional treatments have often fallen short, necessitating innovative approaches to effectively manage OSD. The introduction of device-based therapies, such as the eye-light®, represents a significant advancement in the therapeutic landscape for ocular surface disorders.

Data Highlights

Clinical studies have shown that the combination of OPE™ IPL and LM™ LLLT results in greater improvements in tear film quality and patient symptoms compared to traditional therapies.

Key Findings

• The eye-light® device combines OPE™ IPL and LM™ LLLT for targeted OSD management.
• Clinical studies demonstrate superior efficacy of the dual therapy over long-term eye-drop treatments.
• Results from the light therapies can be maintained for up to 18 months.
• The device is recognized in the TFOS DEWS III Management & Therapy Report as an effective solution for managing OSD.
• Treatment consists of up to four sessions, each lasting approximately 15 minutes.

Clinical Implications

The introduction of the eye-light® device allows eye care practitioners to address the root causes of dry eye and OSD more effectively. This multimodal approach not only enhances patient outcomes but also fosters greater patient trust and loyalty throughout their treatment journey.

Conclusion

The eye-light® device represents a promising advancement in the management of dry eye disease and ocular surface disorders, offering a comprehensive solution that may significantly improve patient quality of life.

Related Resources & Content

1. Essilor Instruments, Essilor Instruments, 2023 -- Dual Light Therapy Device for Dry Eye and OSD Management
2. Ophthalmology Management — Devices Expand Options for Taming Dry Eye
3. Ophthalmology Management — Adding Interventional DED Treatment to Your Practice
4. ophthalmology management — Identifying the Best OSD Treatment for Your Patient
5. Contact Lens Spectrum — DRY EYE DX AND TX
6. Devices Expand Options for Taming Dry Eye
7. Adding Interventional DED Treatment to Your Practice
8. Identifying the Best OSD Treatment for Your Patient
9. TFOS DEWS III: Management and Therapy
10. 21 CFR § 886.5201 - Intense pulsed light device for managing dry eye.
11. A Bright Solution
12. ASCRS PREOPERATIVE
13. OPTOMETRIC CLINICAL
14. Low-level light therapy as an adjunct to intense pulsed light for lipid layer thickness improvement in meibomian gland dysfunction: A randomized trial - ScienceDirect
15. Safety and efficacy of a novel intense pulsed light system in patients with meibomian gland dysfunction: a randomized, double-masked, intra-individual controlled study | International Ophthalmology | Springer Nature Link
16. Long-term efficacy of three treatments for severe MGD: a comparative study in Chinese patients | International Ophthalmology | Springer Nature Link
17. Effectiveness and safety of intense pulsed light therapy for dry eye symptoms due to meibomian gland dysfunction-A systematic review and meta-analysis - PubMed
18. Dry Eye Disease Management Via Technological Methods: A Systematic Review and Network Meta-analysis | Ophthalmology and Therapy | Springer Nature Link